Nine Point Two Capital LLC Evolus, Inc. Transaction History

Nine Point Two Capital LLC

  • $252 Million
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$5.22 - $11.78 $261,709 - $590,602
-50,136 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$5.37 - $8.38 $204,038 - $318,406
37,996 Added 312.98%
50,136 $326,000
Q3 2021

Nov 10, 2021
BUY
$7.36 - $13.67 $89,350 - $165,953
12,140 New
12,140 $92,000

Others Institutions Holding EOLS

# of Institutions
164
Shares Held
46.9M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $800M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Nine Point Two Capital LLC Portfolio

Follow Nine Point Two Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Point Two Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nine Point Two Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email